HCPLive Podcasts

Dr. Louis Kovacs and Dr. Evan Lipson discuss the risk of playing youth, college, and professional sports during the ongoing pandemic.

George Everly, PhD, discusses some of the pitfalls people face due to the ongoing pandemic.

In the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.

Dr. Ian Pavord discusses new meta-analyses of dupilumab planned for ATS 2020.

Panagis Galiatsatos, MD, MHS, joins to discuss the underlying issues and potential solutions to COVID-19 patient disparities.

Discussing a would-be ARVO 2020 presentation examining the use of anterior chamber intracameral dexamethasone drug-delivery suspen for postoperative inflammation in patients undergoing vitreoretinal surgery.

Investigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.

Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.

Al Rizzo, MD, CMO of the American Lung Association, discusses some of the biggest challenges and questions raised on lung health during the coronavirus pandemic.

Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.

Dr. Kaneko, a cardiac surgeon at Brigham and Women's Hospital, breaks down a trio of studies he was associated with from ACC.20, including a look into PLO FLOW TAVR, the July Effect, and alternative access TAVR.

The ORION-11 principal investigator highlights new LDL-C reduction findings and teases future research for the siRNA-targeting drug.

Ralph Sacco, MD, chairman of the Department of Neurology and Olemberg Family Chair in Neurological Disorders Miller Professor of Neurology at the University of Miami, discusses advances in stroke care and his biggest takeaways from ISC 2020.

Anna Lembke, MD, discusses the history of the opioid epidemic.

A discussion on the state of rare disease with Sika Dunyoh, Director of Education Programs at the National Organization of Rare Disorders, for Rare Disease Day 2020.

A discussion on prescribing bempedoic acid in a real-world setting with steering committee chair Christie Ballantyne, MD, chief of Cardiology at Baylor College of Medicine.

David Lee, MD, discusses barbershop initiatives, their effectiveness, applicability in a real-world setting, and how they impact the health of a community as a whole.

Discussing recent TAVR news with Tsuyoshi Kaneko, MD, surgical director and director of outcomes research in the Structural Heart Program at the Brigham and Women's Hospital.

Michael Spigler, vice president of Patient Services and Kidney Disease Education for the American Kidney Fund, talks about the challenges and future of nephrology during Kidney Week.Campfire by Scandinavianz | https://soundcloud.com/scandinavianzMusic promoted by https://www.free-stock-music.comCreative Commons Attribution 3.0 Unported Licensehttps://creativecommons.org/licenses/by/3.0/deed.en_US

A conversation with Deepak Bhatt, MD, MPH, discussing the most impactful advances in cardiology in 2019 and what he sees as the most important advances in the past decade as 2019 comes to a close. ——————————————————————————————————Campfire by Scandinavianz | https://soundcloud.com/scandinavianzMusic promoted by https://www.free-stock-music.comCreative Commons Attribution 3.0 Unported Licensehttps://creativecommons.org/licenses/by/3.0/deed.en_US

Edmund Tsui, MD, social media editor for Ophthalmology, discusses some of the common pitfalls and advantages in the manner some physicians and clinicians navigate social media.

Dr. George Bakris, of the University of Chicago, discusses the impact of canagliflozin approval and how it impacts the current treatment of diabetic kidney disease.

The approval of oral semaglutide, an oral GLP-1 receptor agonist, could mark the beginning of a new era in the treatment of diabetes. We sat down with PIONEER investigator Vanita Aroda, MD, of Brigham and Women's, to learn more about the impact of this approval.

Discussing how changing seasons and weather impact allergy and asthma sufferers with Dr. Lakiea Wright, a board-certified allergist at Brigham and Women's and the medical director of US clinical affairs at Thermo Fisher Scientific. For more information and the latest news in allergy, asthma, and immunology care head to MDMagazine.com

Discussing the known facts and potential dangers of vaping and e-cigarette use with Albert Rizzo, MD, chief medical officer of the American Lung Association. For more information and the latest news in respiratory care, head to MDMagazine.com

Dhruv Kazi, MD, of Beth Israel Deaconess Medical Center, discusses a recent study he led examining use of polypill in several low- and middle-income countries. In this episode, Kazi shares his insights on the study and why polypill seems to be effective but has not become more popular as a treatment for CVD.

Discussing use of AI to determine overall physiological health through a 12-lead ECG. For more on AI in health and the latest in cardiology, be sure to head to MDMagazine.com

Discussing transcatheter aortic valve replacement with Dr. Tsuyoshi Kaneko and Dr. Sameer Hirji, both of Brigham and Women's Hospital. For more on TAVR and the latest in cardiology, be sure to head to MDMagazine.com